{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:37:47Z","timestamp":1784929067813,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["424414\/2018-0"],"award-info":[{"award-number":["424414\/2018-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bbr.2022.113815","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T21:14:26Z","timestamp":1645650866000},"page":"113815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Lower antidepressant response to fluoxetine is associated with anxiety-like behavior, hippocampal oxidative imbalance, and increase on peripheral IL-17 and IFN-\u03b3 levels"],"prefix":"10.1016","volume":"425","author":[{"given":"Brenda Moreira","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele Cheiran","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Piton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda Pessano","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieli","family":"da Silva Carlotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Fernando Muniz","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Guilherme","family":"Ramanzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Marchesan","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane Maria","family":"Zanchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheli Mainardi","family":"Pillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Vargas","family":"Bochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2022.113815_bib1","unstructured":"W.H.O. WHO, Depression - Key facts, Wordl Heal. Organ. 1 (2020) 1\u20134. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"key":"10.1016\/j.bbr.2022.113815_bib2","unstructured":"American Psychiatric Association, DSM-5: manual diagn\u00f3stico e estat\u00edstica de trasntornos mentais, 2014. http:\/\/dislex.co.pt\/images\/pdfs\/DSM_V.pdf."},{"key":"10.1016\/j.bbr.2022.113815_bib3","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatmant Steps: A STAR*D Report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.22968","article-title":"Defining treatment-resistant depression","volume":"37","author":"Gaynes","year":"2020","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.bbr.2022.113815_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of treatment-resistant depression: Challenges and strategies","volume":"16","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2022.113815_bib6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/sj.npp.1301041","article-title":"Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression","volume":"31","author":"Jayatissa","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2022.113815_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuropharm.2011.02.017","article-title":"Modeling treatment-resistant depression","volume":"61","author":"Samuels","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2022.113815_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2014.00208","article-title":"Mechanisms underlying the antidepressant response and treatment resistance","volume":"8","author":"Levinstein","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2022.113815_bib9","first-page":"1","article-title":"Fluoxetine versus other types of pharmacotherapy for depression","volume":"2013","author":"Cipriani","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbr.2022.113815_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2020.00351","article-title":"Neuroprotective Effects of Fluoxetine Against Chronic Stress-Induced Neural Inflammation and Apoptosis: Involvement of the p38 Activity","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbr.2022.113815_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00511","article-title":"Blocking p38 signaling reduces the activation of pro-inflammatory cytokines and the phosphorylation of p38 in the habenula and reverses depressive-like behaviors induced by neuroinflammation","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2022.113815_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02040-8","article-title":"Fluoxetine regulates eEF2 activity (phosphorylation) via HDAC1 inhibitory mechanism in an LPS-induced mouse model of depression","volume":"18","author":"Li","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2022.113815_bib13","first-page":"760","article-title":"Cytokines mediated inflammation and decreased neurogenesis in animal models of depression, Prog. Neuro-Psychopharmacology","volume":"35","author":"Song","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000357500","article-title":"The integrative management of treatment-resistant depression: A comprehensive review and perspectives","volume":"83","author":"Carvalho","year":"2014","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.bbr.2022.113815_bib15","first-page":"23","article-title":"Inflamed moods: A review of the interactions between inflammation and mood disorders, Prog. Neuro-Psychopharmacology","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib16","first-page":"1","article-title":"A meta-analysis of oxidative stress markers in depression","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2022.113815_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","article-title":"Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases, Indian","volume":"30","author":"Phaniendra","year":"2015","journal-title":"J. Clin. Biochem."},{"key":"10.1016\/j.bbr.2022.113815_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/jpet.116.237503","article-title":"Oxidative stress and the central nervous system","volume":"360","author":"Salim","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2022.113815_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbr.2022.113815_bib20","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.2174\/13816128113196660738","article-title":"Oxidative\/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications","volume":"20","author":"Anderson","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbr.2022.113815_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-0835-5","article-title":"Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders","volume":"10","author":"Carvalho","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbr.2022.113815_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2017.05.022","article-title":"Brain antioxidant effect of mirtazapine and reversal of sedation by its combination with alpha-lipoic acid in a model of depression induced by corticosterone","volume":"219","author":"de","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbr.2022.113815_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9501427","article-title":"2,3,5,4\u2032-Tetrahydroxystilbene-2-O-beta-D-glucoside reverses stress-induced depression via inflammatory and oxidative stress pathways","volume":"2018","author":"Jiang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbr.2022.113815_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: A new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.bbr.2022.113815_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbr.2017.04.049","article-title":"Reduced Vesicular Acetylcholine Transporter favors antidepressant behaviors and modulates serotonin and dopamine in female mouse brain","volume":"330","author":"P\u00e1dua-Reis","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2022.113815_bib27","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"M. Le., Jalfre, Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2022.113815_bib28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.psyneuen.2012.09.011","article-title":"Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior","volume":"38","author":"Wu","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2022.113815_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.physbeh.2013.05.012","article-title":"Factors influencing behavior in the forced swim test","volume":"13","author":"Bogdanova","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2022.113815_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00008877-199711000-00011","article-title":"Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze","author":"Anseloni","year":"1997","journal-title":"Bahavioral Pharm."},{"issue":"2014)","key":"10.1016\/j.bbr.2022.113815_bib31","article-title":"Myristic Acid Produces Anxiolytic-Like Effects in Wistar Rats in the Elevated Plus Maze","author":"Contreras","year":"2014","journal-title":"Biomed. Res. Int"},{"key":"10.1016\/j.bbr.2022.113815_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.bbr.2022.113815_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"and Sensitive Method for the Quantitation Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbr.2022.113815_bib34","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/art.38112","article-title":"Transient receptor potential ankyrin 1 receptor stimulation by hydrogen peroxide is critical to trigger pain during monosodium urate-induced inflammation in rodents","volume":"65","author":"Trevisan","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbr.2022.113815_bib35","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","article-title":"The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase","volume":"247","author":"Misra","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2022.113815_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in Vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzym."},{"key":"10.1016\/j.bbr.2022.113815_bib37","first-page":"4","article-title":"The varied clinical presentations of major depressive disorder","volume":"68","author":"Rush","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib38","first-page":"16","article-title":"Treatment-resistant depression","volume":"67","author":"Souery","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.10.063","article-title":"Rodent models of treatment-resistant depression Barbara","volume":"753","author":"Caldarone","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2022.113815_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbr.2018.02.009","article-title":"Antidepressant activity of vorinostat is associated with amelioration of oxidative stress and inflammation in a corticosterone-induced chronic stress model in mice","volume":"344","author":"Athira","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2022.113815_bib41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejphar.2018.07.002","article-title":"Cholecalciferol counteracts depressive-like behavior and oxidative stress induced by repeated corticosterone treatment in mice","volume":"833","author":"Camargo","year":"2018","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.bbr.2022.113815_bib42","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.euroneuro.2019.06.001","article-title":"Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis","volume":"29","author":"Perugi","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2022.113815_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13651501.2016.1248852","article-title":"Evidence-based pharmacotherapy of treatment-resistant unipolar depression","volume":"21","author":"Dold","year":"2016","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.bbr.2022.113815_bib44","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","article-title":"Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress","author":"Berton","year":"2006","journal-title":"Sci. (80-. ). 311"},{"key":"10.1016\/j.bbr.2022.113815_bib45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","article-title":"Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions","volume":"131","author":"Krishnan","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2022.113815_bib46","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12640-017-9835-5","article-title":"Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia","volume":"33","author":"Sowa-K\u00facma","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbr.2022.113815_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2013.09.033","article-title":"Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress","volume":"1539","author":"Patki","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2022.113815_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbi.2012.11.011","article-title":"Dysregulated relationship of inflammation and oxidative stress in major depression","volume":"31","author":"Rawdin","year":"2013","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbr.2022.113815_bib49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2174\/1570159X13666150630175044","article-title":"Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review","volume":"13","author":"Rosenblat","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbr.2022.113815_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9123793","article-title":"Peripheral markers of depression","volume":"9","author":"Nobis","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbr.2022.113815_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112643","article-title":"Apocynin as an antidepressant agent: in vivo behavior and oxidative parameters modulation","volume":"388","author":"Pereira","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2022.113815_bib52","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2174\/1381612826666200406090051","article-title":"Vitamin D and N-Acetyl Cysteine Supplementation in Treatment-Resistant Depressive Disorder Patients: A General Review","volume":"26","author":"di Michele","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbr.2022.113815_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2019.00423","article-title":"Glucocorticoid resistance: Is it a requisite for increased cytokine production in depression? A systematic review and meta-analysis","volume":"10","author":"Perrin","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01343-5","article-title":"Comparison of hypothalamo-pituitary-adrenal function in treatment resistant unipolar and bipolar depression","volume":"11","author":"Markopoulou","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2018.00185","article-title":"Cortisol modulation by ayahuasca in patients with treatment resistant depression and healthy controls","volume":"9","author":"Galv\u00e3o","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib56","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Beyond Colonialism, Development and Globalization: Social Movements and Critical Perspectives","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbr.2022.113815_bib57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3109\/09540261.2013.813442","article-title":"Cytokines as biomarkers in depressive disorder: Current standing and prospects","volume":"25","author":"Lichtblau","year":"2013","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbr.2022.113815_bib59","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: A meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2022.113815_bib60","first-page":"722","article-title":"Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression, Prog. Neuro-Psychopharmacology","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib61","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopsych.2008.08.010","article-title":"Activation of CNS Inflammatory Pathways by Interferron-alpha: Rlationship to Monoamines and Depression","volume":"65","author":"Raison","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib62","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1073\/pnas.1914655117","article-title":"Molecular adaptations of the blood\u2013brain barrier promote stress resilience vs. Depression","volume":"117","author":"Dudek","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbr.2022.113815_bib63","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41386-020-00948-6","article-title":"Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial","volume":"46","author":"Nettis","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2022.113815_bib64","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbr.2022.113815_bib65","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-\u03b1 in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2022.113815_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/tp.2016.274","article-title":"Recurrence of depressive disorders after interferon-induced depression","volume":"7","author":"Chiu","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.649144","article-title":"Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2022.113815_bib68","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.20091419","article-title":"Regulation of learning and memory by meningeal immunity: A key role for IL-4","volume":"207","author":"Derecki","year":"2010","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.bbr.2022.113815_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.03.004","article-title":"Participation of interleukin 17A in neuroimmune interactions","volume":"41","author":"Moynes","year":"2014","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbr.2022.113815_bib70","first-page":"28","article-title":"Th17 cells in depression El\u00e9onore","volume":"69","author":"Beurel","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2022.113815_bib71","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.biopsych.2012.09.021","article-title":"Inflammatory Th17 cells promote depression-like behavior in mice","volume":"73","author":"Beurel","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113815_bib72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbi.2017.07.005","article-title":"Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection","volume":"66","author":"Jha","year":"2017","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbr.2022.113815_bib73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/15622975.2019.1618494","article-title":"Cytokine-mediated cellular immune activation in electroconvulsive therapy: A CSF study in patients with treatment-resistant depression, World","volume":"21","author":"Mindt","year":"2020","journal-title":"J. Biol. Psychiatry"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:32:36Z","timestamp":1759066356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432822000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":73,"alternative-id":["S0166432822000833"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2022.113815","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower antidepressant response to fluoxetine is associated with anxiety-like behavior, hippocampal oxidative imbalance, and increase on peripheral IL-17 and IFN-\u03b3 levels","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2022.113815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113815"}}